147 related articles for article (PubMed ID: 37517205)
1. Synthesis and pharmacodynamic evaluation of naphthalene derivatives against influenza A virus in vitro and in vivo.
Ge Y; Zhang C; Qu Y; Ding L; Zhang X; Zhang Z; Jin C; Wang XN; Wang Z
Eur J Med Chem; 2023 Nov; 259():115660. PubMed ID: 37517205
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
4. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.].
Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI
Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059
[TBL] [Abstract][Full Text] [Related]
5. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
6. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and mechanism of salmeterol against influenza A virus in vitro and in vivo.
Zhao J; Xu L; Bai Y; Wang C; Guo P; Wang Z; Du G; Liu A
Int Immunopharmacol; 2023 Jun; 119():110226. PubMed ID: 37159964
[TBL] [Abstract][Full Text] [Related]
8. Influenza A(H1N1)pdm09 virus suppresses RIG-I initiated innate antiviral responses in the human lung.
Wu W; Zhang W; Booth JL; Metcalf JP
PLoS One; 2012; 7(11):e49856. PubMed ID: 23185463
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of influenza virus replication by Apiaceae plants, with special reference to Peucedanum japonicum (Sacna) constituents.
Kanazawa R; Morimoto R; Horio Y; Sumitani H; Isegawa Y
J Ethnopharmacol; 2022 Jun; 292():115243. PubMed ID: 35358620
[TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
11. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
12. Screening and identification of 3-aryl-quinolin-2-one derivatives as antiviral agents against influenza A.
Cheng H; Fu L; Yang X; Yang Y; Zhang Z; Tao Y; Wan J; Tu Z; Chen J; Li Y
J Med Virol; 2023 Jan; 95(1):e28327. PubMed ID: 36415105
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL
PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Activity of Honeysuckle Extracts against Influenza A Virus In Vitro and In Vivo.
Li M; Wang Y; Jin J; Dou J; Guo Q; Ke X; Zhou C; Guo M
Virol Sin; 2021 Jun; 36(3):490-500. PubMed ID: 33044658
[TBL] [Abstract][Full Text] [Related]
16. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo.
Li Z; Zhao J; Zhou H; Li L; Ding Y; Li J; Zhou B; Jiang H; Zhong N; Hu W; Yang Z
Life Sci; 2018 May; 200():115-125. PubMed ID: 29555588
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
[TBL] [Abstract][Full Text] [Related]
18. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of alkoxy-substituted enamides against influenza A virus in vitro and in vivo.
Liu Z; Ge Y; Ding L; Zhang Z; Qu Y; Jin C; Wang XN; Wang Z
Bioorg Chem; 2023 Oct; 139():106712. PubMed ID: 37421691
[TBL] [Abstract][Full Text] [Related]
20. Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites.
Han YJ; Lee KM; Wu GH; Gong YN; Dutta A; Shih SR
J Biomed Sci; 2023 Feb; 30(1):10. PubMed ID: 36737756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
